article thumbnail

First plaintiff in Zantac litigation drops suit against drug manufacturers

JURIST

The first plaintiff scheduled to go to trial against drug manufacturers for the heartburn medication Zantac Tuesday dropped his suit. ranitidine) caused him to develop esophageal cancer, told the court and drug manufacturers that he intended to file a notice of voluntary dismissal. Joseph Bayer, who claimed Zantac (also known as ??ranitidine)

article thumbnail

“First Circuit Allows Some of Mexico’s Claims Against Gun Manufacturers to Move Forward”

HowAppealing

“First Circuit Allows Some of Mexico’s Claims Against Gun Manufacturers to Move Forward”: William S. Dodge has this post at the “Transnational Litigation Blog.” ” The post “First Circuit Allows Some of Mexico’s Claims Against Gun Manufacturers to Move Forward” appeared first on How Appealing.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Opioid manufacturer Teva Pharmaceuticals announces $4.35B settlement with state, local governments

JURIST

Opioid manufacturer Teva Pharmaceuticals Industries Tuesday announced a $4.35 Teva is an Israeli multinational pharmaceutical company which manufactures prescription medication including opioids. Teva is an Israeli multinational pharmaceutical company which manufactures prescription medication including opioids.

article thumbnail

Arkansas Law Prohibiting Manufacturer 340B Contract Pharmacy Restrictions Upheld by 8th Circuit

FDA Law Blog

By Faraz Siddiqui — As drug manufacturers battle the Health Resources and Services Administration (“HRSA”) in federal courts over the role of 340B contract pharmacies, an Eighth Circuit decision to uphold a 2021 Arkansas law may render those cases inconsequential in that state. Code Ann. § 23-92-604(c)(1), (2) (Act 1103).

article thumbnail

Opioid manufacturer Teva Pharmaceuticals announces $523M settlement with New York state

JURIST

New York Attorney General Letitia James Thursday reached a $523 million settlement with opioid manufacturer Teva Pharmaceuticals Industries. Commenting on the settlement, James said: I made a promise to put an end to the havoc wreaked by opioid manufacturers in New York and across the nation and to hold them accountable for the consequences.

article thumbnail

Canada: Federal Court Approves Litigation Funding Agreement In Proposed Class Proceeding Against Generic Drug Manufacturers - Smart & Biggar

Mondaq

As previously reported, a proposed class action proceeding against over 50 generic drug manufacturers was commenced in 2020.

article thumbnail

Worldwide: Climate Change And ESG Litigation Trends In The Consumer Sector (Podcast) - Herbert Smith Freehills

Mondaq

Mark Smyth and Jojo Fan discuss the rapidly increasing developments in climate change and ESG litigation globally including greenwashing, inadequate disclosure and challenges for manufacturing and governments.